AI analysis for lexter-trebor
My AI analyses | Archived analysis
Financial instrument | Status | Timeframe | Opinion | Targets | Force | ||
---|---|---|---|---|---|---|---|
CHARGEURS
|
INVALID | Weekly | 14.95
| 11.97 (-16.18%) 10.61 (-25.70%) |
5.5 |
|
|
ABIVAX
|
INVALID | Weekly |
| 25.45 (+6.26%) | 8.8 |
|
|
INNATE PHARMA
|
TARGET REACHED | Daily | 6.080
| 5.399 (-3.76%) 5.073 (-9.57%) |
5.5 |
|
|
QUANTUM GENOMICS
|
TARGET REACHED | Weekly | 3.3120
| 2.5670 (-9.93%) 2.2330 (-21.65%) |
2.5 |
|
|
QUANTUM GENOMICS
|
TARGET REACHED | Weekly | 2.9850
| 2.3500 (-15.16%) 1.8840 (-31.99%) |
3 |
|
|
DBT
|
INVALID | Daily |
| 0.4210 (+58.87%) 0.5300 (+100.00%) |
6.4 |
|
|
CHARGEURS
|
TARGET REACHED | Weekly | 16.51
| 13.91 (-8.37%) 11.30 (-25.56%) |
5 |
|
|
QUANTUM GENOMICS
|
TARGET REACHED | Weekly | 2.9850
| 2.3500 (-15.77%) 1.8840 (-32.47%) |
3 |
|
|
TME PHARMA
|
NEUTRAL | Weekly | 0.6110
| - | - |
|